Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6-LYN gene fusion
2016
Myeloproliferative neoplasms (MPNs) are a heterogeneous group of clonal haematopoietic stem cell disorders characterised by proliferation and maturation of different myeloid cell lineages. Classical MPNs are largely characterised by somatic mutation of JAK2, CALR or occasionally MPL genes.1, 2 MPNs can develop from chromosomal translocations forming gene fusions, involving constitutive activation and aberrant expression of tyrosine kinase (TK). Other than the BCR-ABL1 rearrangement in chronic myeloid leukaemia, gene fusions involving TK proto-oncogenes are rare in MPN but when detected, provide compelling disease-specific therapeutic targets.3 Myeloproliferative and lymphoid neoplasms with eosinophilia and specific TK gene fusions are a recently described, rare entity of clinical significance due to varying responsiveness to tyrosine kinase inhibitors (TKIs).4 The three cytogenetic categories identified, involving fusions of PDGFRA, PDGFRB or FGFR1 with different partner genes, are thought to affect a pluripotent stem cell and have variable presentation as MPN with eosinophilia, occasionally with a T-lymphoid disease component. Excellent response rates and long-term clinical outcomes have been reported with abnormalities of PDGFRA and PDGFRB treated with imatinib, whereas disorders with FGFR1 and JAK2 gene fusions are resistant to imatinib and other TKIs. We present a case of a disease fitting within this clinical and haematological spectrum, with a chromosomal rearrangement between chromosomes 8 and 12, bearing ETV6–LYN gene fusion.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
8
Citations
NaN
KQI